Molecularly Aided Stratification for Tumor Eradication Research
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGerman Cancer Research Center
About this trial
NCT/DKFZ/DKTK MASTER is a prospective, continuously recruiting, multicenter observational study for biology-guided stratification of adults with rare cancers, including rare subtypes of common entities, using comprehensive molecular profiling, and clinical decision-making in a multidisciplinary molecular tumor board.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
patients from university hospital Heidelberg and all German Consortium for Translation Research sites
Trial design
Design model
Other
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
progression free survival
Time period of progression survival from date of multiomics analysis
Time frame
5 years2
overall survival
time period of survival from date of diagnosis
Time frame
10 yearsSecondary outcomes
1
response to antitumor treatment
response according to RECIST v.1.1 criteria to antitumor treatment applied after multiomics analysis
Time frame
5 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
German Cancer Research Center
Lead sponsor
German Consortium for Translational Cancer Research
Collaborator
Source ClinicalTrials.gov